Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

aTYR PHARMA (ATYR) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for aTYR PHARMA (ATYR) over the last 2 years, with Q3 2025 value amounting to -$3.9 million.

  • aTYR PHARMA's Other Operating Expenses fell 3885.71% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year decrease of 6290.27%. This contributed to the annual value of -$11.4 million for FY2024, which is 450.0% down from last year.
  • aTYR PHARMA's Other Operating Expenses amounted to -$3.9 million in Q3 2025, which was down 3885.71% from -$3.9 million recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Other Operating Expenses ranged from a high of -$2.8 million in Q2 2024 and a low of -$3.9 million during Q2 2025